TITLE

Biointegration of the Osteo-odonto Lamina in the Modified Osteo-odonto Keratoprosthesis: Engineering of Tissue to Restore Lost Vision

AUTHOR(S)
Sawatari, Yoh; Marx, Robert E.; Perez, Victor L.; Parel, Jean-Marie
PUB. DATE
June 2011
SOURCE
Oral & Craniofacial Tissue Engineering;2011, Vol. 1 Issue 2, p112
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The modified osteo-odonto keratoprosthesis (MOOKP) is a biologic keratoprosthesis that is used to treat a severely scarred cornea. The procedure involves multiple stages, including the transplantation of buccal mucosa to the damaged ocular surface and the implantation of an osteo-odonto lamina with a mounted polymethylmethacrylate lens. Among the keratoprostheses currently available, the MOOKP has proven to be the most effective based on the number of patients who have undergone the procedure and the duration of documented follow-up. Upon successful biointegration of the osteo-odonto lamina, the keratoprosthesis is able to resist resorption, provide stability, and prevent bacterial invasion and epithelial ingrowth. The effectiveness of the MOOKP is dependent on the anatomic and physiologic characteristics of the dental tissues and periodontal ligament.
ACCESSION #
64753615

 

Related Articles

  • Boston type I keratoprosthesis. Review. MAGALHÃES, FERNANDA PEDREIRA; DE SOUSA, LUCIENE BARBOSA; DE OLIVEIRA, LAURO AUGUSTO // Arquivos Brasileiros de Oftalmologia;2012, Vol. 75 Issue 3, p218 

    Regardless of significant progress in the field of corneal transplantation to treat corneal opacification, some cases of corneal blindness still present a poor prognosis for conventional penetrating keratoplasty. In patients with repeated graft failure and/or with severe ocular surface disease,...

  • Artificial corneas yield long-term vision. Talsma, Julia; Alfonso, Eduardo C. // Ophthalmology Times;6/15/2004, Vol. 29 Issue 12, p1 

    Looks into the development of artificial corneas for patients who are not good candidates for the current techniques of keratoplasty in the U.S. Identification of the approaches undertaken for these patients; Characteristics of the ideal keratoprostheses; Prevention of endophthalmitis.

  • Osteo-odontal keratoprosthesis revives old technique. Charters, Lynda // Ophthalmology Times;10/01/97, Vol. 22 Issue 19, p84 

    Focuses on osteo-odontal keratoprosthesis, a technique that uses a segment of a patient's tooth to fashion a frame for an optical cylinder that acts as an artificial cornea. Outline of the procedure; Historical background on the origin of the technique; Medical conditions of patients qualified...

  • New artificial cornea offers promise for transplant patients. Scerra, Chet // Ophthalmology Times;8/1/2004, Vol. 29 Issue 15, p10 

    Reports on an artificial cornea from Argus Biomedical Pty. Ltd. Replacement of a scarred or diseased native cornea in patients for whom corneal graft using human donor tissue is unsuitable.

  • Abstracts of Papers.  // Journal of Dental Research;Jul1971, Vol. 50 Issue 4, p797 

    Abstracts for several papers are presented, including "Oral Ulceration: Clinical Aspects," "Dermal-Epidermal Interactions," and "Allergy in Surface Lesions of the Oral Mucosa."

  • Tooth in eye surgery. Kaur, N.; Nagpal, A. // British Dental Journal;4/27/2013, Vol. 214 Issue 8, p373 

    A letter to the editor is presented regarding tooth in eye surgery or osteo-odonto keratoprosthesis (OOKP), which is an artificial cornea surgery to restore vision of a patient with corneal blindness.

  • Evolving techniques enhance results with keratoprosthesis. Guttman, Cheryl // Ophthalmology Times;7/15/2005, Vol. 30 Issue 14, p24 

    Reports on the use of the AlphaCor synthetic keratoprosthesis from Argus Biomedical in the U.S. Identification of risk factors for complications along with the development of protective procedures that are enabling better outcomes; Role of the evolving surgical technique and developments in...

  • Artificial Cornea Released. Luntz, Stephen // Australasian Science;Jul2002, Vol. 23 Issue 6, p8 

    Reports on the plan for the commercial release of AlphaCor, an artificial cornea developed at Lions Eye Institute in Western Australia as of July 2002. Method in the manufacture of AlphaCor; Results of the clinical trial; Complications from the use of AlphaCor.

  • Visual rehabilitation in end-stage inflammatory ocular surface disease with the osteo-odonto- keratoprosthesis: results from the UK. Liu, C.; Okera, S.; Tandon, H.; Herold, J.; Hull, C.; Thorp, S. // British Journal of Ophthalmology;Sep2008, Vol. 92 Issue 9, p1211 

    Aims: To report the long-term results of osteo-odonto-keratoprosthesis (OOKP) surgery in the visual rehabilitation of patients with corneal blindness from end-stage inflammatory ocular surface disease. Methods: A non-comparative retrospective case series of 36 consecutive patients treated at the...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics